Lee, Gwan-Ho Oh, Min-Seok Park, Min-Ho Shin, Young G. Song, Jong Han Yu, Byung-Yong 2024-01-19T22:33:49Z 2024-01-19T22:33:49Z 2021-09-03 2018-06 0253-2964 https://pubs.kist.re.kr/handle/201004/121342 Identifying drug-drug interactions, potentially affecting efficacy and safety of each drug is essential for drug development. Microdose, administration of a drug at less than 100 mu g or 1/100 of its therapeutic dose, is a promising method to safely test drugs during development. This paper examines drug-drug interactions between therapeutic doses of ciprofloxacin and trace amounts of C-14-caffeine for microdosing in mice using AMS for analysis. The pharmacokinetic (PK) parameters for caffeine with and without administration of ciprofloxacin did not show any change in T-max. However, the values of T-1/2, C-max, and AUC(inf) with administration of ciprofloxacin increased by 57, 22, and 42%, respectively. This is in agreement with previous studies that used full prescription doses. It is shown here that microdose techniques combined with AMS measurements can be used for accurate prediction of drug-drug interactions while conducting relatively safe, small dose studies. English 대한화학회 Study of Ultra-Sensitive AMS Method to Identify Drug-Drug Interactions between Ciprofloxacin and Microdose C-14-Caffeine Article 10.1002/bkcs.11468 1 Bulletin of the Korean Chemical Society, v.39, no.6, pp.773 - 777 Bulletin of the Korean Chemical Society 39 6 773 777 N scie scopus kci ART002352569 000434351200011 2-s2.0-85048255063 Chemistry, Multidisciplinary Chemistry Article ACCELERATOR MASS-SPECTROMETRY CAFFEINE BIOAVAILABILITY CLEARANCE HUMANS AMS Microdose Drug-drug interaction Caffeine CYP1A2